用RWE加速治疗状细胞疾病的新疗法:ASH RC数据中心作为战略协调的注册表网络数据中心
William A Wood1, Osman N Yogurtcu2, Emily Semmel3
1University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
Blood advances
|August 8, 2025
概括
对状细胞疾病 (SCD) 的现实世界证据 (RWE) 产生正在通过一个协作数据中心 (Data Hub) 取得进展. 该倡议旨在改善患者护理,并利用精选的患者数据加快创新疗法的评估.
科学领域:
- 现实世界的证据 (RWE) 产生和应用在血液学中.
- 数据科学和医疗保健研究的信息学.
- 状细胞疾病 (SCD) 研究和临床管理.
背景情况:
- 现实世界的证据 (RWE) 对于改善护理,促进创新和评估疗法至关重要.
- 协调注册表网络 (CRN) 模型,汇总精选的患者数据,是关键的RWE生成策略.
- 该ASH研究协作® (ASH RC) 数据中心使用CRN模型来推进RWE生成.
研究的目的:
- 评估和为ASH研究协作 (ASH RC) 状细胞疾病 (SCD) 数据中心提供建议.
- 评估数据中心对监测新疗法的RWE指南的标准化.
- 评估患者参与和利益相关者之间的合作,包括监管机构,行业和临床医生.
主要方法:
- 由ASH RC和创新基因组学研究所 (IGI) 共同发起的一项倡议,旨在利用RWE加强SCD研究.
- 一个专家小组使用了一个"成熟度模型"来评估数据中心标准化和参与度.
- 从电子健康记录收集数据,将来将基因疗法数据纳入其中.
主要成果:
- 目前,SCD数据中心正在收集22家美国医院约27000名SCD患者的数据.
- 该计划涉及56个中心,计划将队列扩大到大约5万名患者.
- 该CRN模型的结构通过多站点协作和多样化的证据需求促进创新.
结论:
- 使用CRN模型的ASH RC数据中心是为SCD推进RWE生成的重要一步.
- 该倡议旨在加强临床护理,加快证据生成,加快治疗创新.
- 合作关系和强大的数据标准化是成功生成新疗法RWE的关键.
更多相关视频
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
10.0K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.6K
相关概念视频
01:30Continuous Renal Replacement Therapy
143
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
143
01:22Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K